Form DEFC14A - Definitive proxy statement, contested solicitations:
SEC Accession No. 0000921895-23-002326
Filing Date
2023-10-10
Accepted
2023-10-10 10:33:03
Documents
2

Document Format Files

Seq Description Document Type Size
1 defc14a13392004_10102023.htm DEFC14A 284182
2 GRAPHIC image_001.jpg GRAPHIC 24070
  Complete submission text file 0000921895-23-002326.txt   319189
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Subject) CIK: 0001262104 (see all company filings)

EIN.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEFC14A | Act: 34 | File No.: 001-41827 | Film No.: 231316421
SIC: 2834 Pharmaceutical Preparations

Mailing Address 16000 DALLAS PARKWAY SUITE 800 DALLAS TX 75248
Business Address 16000 DALLAS PARKWAY SUITE 800 DALLAS TX 75248 214.866.0202
Anson Funds Management LP (Filed by) CIK: 0001491072 (see all company filings)

EIN.: 300134498 | State of Incorp.: TX | Fiscal Year End: 1231
Type: DEFC14A